Background The aim of this study was to evaluate the efficacy

Background The aim of this study was to evaluate the efficacy of the p53-reactivating medicines RITA and nutlin3a in killing myeloma cells. of myeloma cells. The apoptosis that was induced by (R)-P7C3-Ome RITA was not related to the status of the cell lines or the del17p status of the primary samples (p = 0.52 and… Continue reading Background The aim of this study was to evaluate the efficacy